Validation of the French Translation of the Movement Disorder Society Non-Motor Symptoms Scale (MDS-NMS) in Parkinson's Disease.
Saved in:
| Title: | Validation of the French Translation of the Movement Disorder Society Non-Motor Symptoms Scale (MDS-NMS) in Parkinson's Disease. |
|---|---|
| Authors: | Desjardins C; Department of Neurology, Foundation Rothschild Hospital, Paris Cité Université, Paris, France., Grimaldi S; Department of Neurology and Movement Disorders, AP-HM, CHU La Timone, Marseille, France., Luo S; Duke University, Durham, NC, USA., Yu L; Duke University, Durham, NC, USA., Goetz CG; Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA., Stebbins GT; Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA., Martinez-Martin P; Centro de Investigacion Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain., Kurtis MM; Hospital Ruber Internacional, Madrid, Spain., Mestre TA; Parkinson's Disease and Movement Disorders Clinic, Division of Neurology, Department of Medicine, The Ottawa Hospital Research Institute, Ottawa, ON, Canada.; University of Ottawa Brain and Mind Institute, Ottawa, ON, Canada., Sanchez-Ferro A; Centro de Investigacion Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.; Movement Disorders Unit, Neurology Department, Hospital Universitario 12 de Octubre, Madrid, Spain., Tosin MHS; Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA., Balestrino R; Vita-Salute San Raffaele University, Milan, Italy.; Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Neurology and Neurorehabilitation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy., Lin CR; Baylor College of Medicine, Houston, TX, USA., Gasca-Salas C; Centro de Investigacion Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.; HM CINAC (Centro Integral de Neurociencias Abarca Campal), Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid, Spain.; School of Medicine, University CEU-San Pablo, Madrid, Spain., Witjas T; Department of Neurology and Movement Disorders, AP-HM, CHU La Timone, Marseille, France., Colin O; Department of Neurology, CH Brive, Limoges Parkinson Expert Centre, French NS-Park/F-CRIN Network, Brieve, France., Maltete D; Department of Neurology, NS-PARK/FCRIN Network, Rouen University Hospital and University of Rouen, Rouen, France.; INSERM U1239, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan, France., Defebvre L; Movement Disorders Department, Lille University, Lille, France., Giordana C; Department of Neurology, Centre Hospitalier Universitaire de Nice, Université Côte d'Azur, Nice, France., Charif M; Department of Neurology, CHRU Montpellier, Montpellier, France., Thiriez C; Department of Neurology and Parkinson Expert Centre, Caen University-Hospital, Caen, France., Laurencin C; Department of Neurology C, Parkinson Expert Center, Pierre Wertheimer Neurological Hospital, Hospices Civils de Lyon, Bron, France., Tir M; Department of Neurology, University Hospital of Amiens, Amiens, France., Dupont G; Département de Neurologie, Centre Hospitalier Universitaire François Mitterrand, Université de Bourgogne, Dijon, France., Remy P; Centre Expert Parkinson, Neurologie, CHU Henri Mondor, AP-HP, Equipe 01-NPI, IMRB INSERM et Ecole Normale Supérieure, Faculté de Santé, Université Paris-Est Créteil, Créteil, France., Tranchant C; Service de Neurologie, NS-PARK/FCRIN Network, Hôpitaux Universitaires de Strasbourg, Strasbourg, France., Drapier S; Department of Neurology, CIC 1414, Rennes University Hospital and NS-Park/FCRIN Network, Rennes, France., Samier A; CHU Bordeaux, Service de Neurologie des Maladies Neurodégénératives, and NS-Park/FCRIN Network IMNc, Bordeaux, France., Benatru I; Department of Neurology, University Hospital of Poitiers, Poitiers, France., Sambin S; Sorbonne Université, Paris Brain Institute-ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, CIC Neusociences, Pitié-Salpêtrière Hospital, France Sorbonne Université, Paris, France., Corvol JC; Sorbonne Université, Paris Brain Institute-ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, CIC Neusociences, Pitié-Salpêtrière Hospital, France Sorbonne Université, Paris, France., Khelifi F; NS-Park Network, Toulouse, France., Fabbri M; NS-Park Network, Toulouse, France.; Department of Clinical Pharmacology and Neurosciences, Toulouse Parkinson Expert Centre, Toulouse NeuroToul Center of Excellence in Neurodegeneration (COEN), French NS-Park/F-CRIN Network, University of Toulouse 3, CHU of Toulouse, INSERM, Toulouse, France., Rascol O; NS-Park Network, Toulouse, France.; Department of Clinical Pharmacology and Neurosciences, Toulouse Parkinson Expert Centre, Toulouse NeuroToul Center of Excellence in Neurodegeneration (COEN), French NS-Park/F-CRIN Network, University of Toulouse 3, CHU of Toulouse, INSERM, Toulouse, France. |
| Corporate Authors: | NS‐Part Cohort study group and the MDS COA Translation Steering Committee |
| Source: | Movement disorders clinical practice [Mov Disord Clin Pract] 2026 Feb; Vol. 13 (2), pp. 575-579. Date of Electronic Publication: 2025 Sep 01. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101630279 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2330-1619 (Electronic) Linking ISSN: 23301619 NLM ISO Abbreviation: Mov Disord Clin Pract Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
